Vlado Perkovic

Vlado Perkovic

UNVERIFIED PROFILE

Are you Vlado Perkovic?   Register this Author

Register author
Vlado Perkovic

Vlado Perkovic

Publications by authors named "Vlado Perkovic"

Are you Vlado Perkovic?   Register this Author

100Publications

3134Reads

46Profile Views

Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial.

Nephrology (Carlton) 2019 Oct 29;24(10):1056-1063. Epub 2019 Apr 29.

The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/nep.13530DOI Listing
October 2019

Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program.

Diabetologia 2019 Oct 10;62(10):1854-1867. Epub 2019 Aug 10.

The George Institute for Global Health, UNSW Sydney, Level 5, 1 King St, Newtown, Sydney, NSW, 2042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-019-4955-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731200PMC
October 2019

Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering.

CMAJ 2019 Oct;191(41):E1128-E1135

The George Institute for Global Health (Neuen, Jardine, Perkovic), University of New South Wales, Sydney, Australia; Division of Nephrology (Cherney), Departments of Medicine and Physiology, University Health Network, University of Toronto, Toronto, Ont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.190047DOI Listing
October 2019

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.

Lancet Diabetes Endocrinol 2019 Sep 5. Epub 2019 Sep 5.

The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia; Concord Repatriation and General Hospital, Sydney, NSW, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(19)30256-6DOI Listing
September 2019

Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial.

Nephrol Dial Transplant 2019 Sep 8. Epub 2019 Sep 8.

Department of Medicine, Würzburg University Clinic, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfz179DOI Listing
September 2019

Canagliflozin and Renal Outcomes in Diabetic Nephropathy. Reply.

N Engl J Med 2019 09;381(11):1089-1090

George Institute for Global Health, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1909687DOI Listing
September 2019

Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.

Ann Intern Med 2019 Aug 16;171(3):181-189. Epub 2019 Jul 16.

The George Institute for Global Health, UNSW Medicine, and St. George Hospital, Sydney, New South Wales, Australia (J.T.H., L.P.C., S.V.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M19-0087DOI Listing
August 2019

Blood pressure: at what level is treatment worthwhile?

Aust Prescr 2019 Aug 1;42(4):127-130. Epub 2019 Aug 1.

The George Institute for Global Health, UNSW Sydney.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18773/austprescr.2019.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698244PMC
August 2019

Is it time to REWIND the cardiorenal clock in diabetes?

Lancet 2019 07 9;394(10193):95-97. Epub 2019 Jun 9.

Department of Renal Medicine, Royal North Shore Hospital, St Leonards, NSW, Australia; Renal and Metabolic Division, The George Institute for Global Health, University of New South Wales Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(19)31267-XDOI Listing
July 2019

Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease: A Meta-analysis.

JAMA Intern Med 2019 Jul 8. Epub 2019 Jul 8.

The George Institute for Global Health and University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2019.1501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618769PMC
July 2019

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

N Engl J Med 2019 06 14;380(24):2295-2306. Epub 2019 Apr 14.

From the George Institute for Global Health, University of New South Wales Sydney (V.P., M.J.J., B.N., S. Bompoint), the Royal North Shore Hospital (V.P.), Concord Repatriation General Hospital (M.J.J.), and the Charles Perkins Centre, University of Sydney (B.N.), Sydney, and the Kolling Institute of Medical Research, Sydney Medical School, University of Sydney, Royal North Shore Hospital, St. Leonards, NSW (C.P.) - all in Australia; Imperial College London (B.N.) and the Department of Renal Medicine, UCL Medical School (D.C.W.) - both in London; the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands (H.J.L.H., D.Z.); the Nephrology Division, NYU School of Medicine and NYU Langone Medical Center, New York (D.M.C.); Baim Institute for Clinical Research (D.M.C., C.P.C., B.M.B.), the Cardiovascular Division (C.P.C.) and the Renal Division and Department of Medicine (B.M.B), Brigham and Women's Hospital, and Harvard Medical School (B.M.B.) - all in Boston; Janssen Research and Development, Raritan, NJ (R.E., S. Bull, G.C., P.-L.C., Y.Y., G.M.); Indiana University School of Medicine and Veterans Affairs Medical Center, Indianapolis (R.A.); the Department of Medicine, University of Chicago Medicine, Chicago (G.B.); the Division of Biostatistics, Department of Population Health Sciences, University of Utah, Salt Lake City (T.G.); the Division of Nephrology, University of British Columbia, Vancouver (A.L.), and the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.) - all in Canada; the Renal Division, Peking University First Hospital, Beijing (H.Z.); and the Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1811744
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1811744DOI Listing
June 2019

Combination of Changes in Estimated GFR and Albuminuria and the Risk of Major Clinical Outcomes.

Clin J Am Soc Nephrol 2019 Jun 3;14(6):862-872. Epub 2019 Jun 3.

The George Institute for Global Health, University of New South Wales, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.13391118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556720PMC
June 2019

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int 2019 May;95(5):1027-1036

KfH Kidney Center, Munich, Germany; Department of Nephrology and Hypertension, University Hospital, Friedrich-Alexander University, Erlangen-Nuremberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.12.025DOI Listing
May 2019

Effect of extended hours dialysis on sleep quality in a randomized trial.

Nephrology (Carlton) 2019 Apr;24(4):430-437

Renal & Metabolic Division, The George Institute for Global Health, UNSW, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/nep.13236
Publisher Site
http://dx.doi.org/10.1111/nep.13236DOI Listing
April 2019

New hypoglycemic agents and the kidney: what do the major trials tell us?

F1000Res 2018 23;7. Epub 2018 Nov 23.

The George Institute for Global Health, UNSW, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.16135.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259591PMC
March 2019

Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial.

CMAJ 2019 Mar;191(9):E247-E256

Division of Nephrology (Garg, Cuerden, Sontrop), Department of Medicine, London Health Sciences Centre, London, Ont.; Department of Anaesthesia and Intensive Care (Chan), The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Departments of Health Research Methods, Evidence, and Impact, and Medicine (Devereaux, Walsh), McMaster University, Hamilton, Ont.; Tehran Heart Center (Abbasi), Tehran University of Medical Sciences, Tehran, Iran; Division of Nephrology (Hildebrand), Department of Medicine, University of Alberta, Edmonton, Alta.; Département de médecine (Lamontagne), Faculté de médecine et des sciences de la santé, Université de Sherbrooke, Sherbrooke, Que.; Department of Surgery (Lamy) McMaster University, Hamilton, Ont.; Department of Cardiac Surgery (Noiseux), Université de Montréal, Montréal, Que.; Division of Nephrology, Johns Hopkins School of Medicine (Parikh), Baltimore, Md.; The George Institute for Global Health (Perkovic), Sydney, Australia; Division of Cardiac Surgery (Quantz), London Health Sciences Centre, University Hospital, London, Ont.; Montreal Heart Institute (Rochon), Université de Montréal, Montréal, Que.; Department of Surgery (Royse), University of Melbourne, Melbourne, Australia; Department of Outcomes Research (Sessler), Cleveland Clinic, Cleveland, Ohio; Department of Cardiac Surgery (Shah), Princess Alexandra Hospital, Brisbane, Australia; Department of Cardiovascular and Thoracic Surgery (Tagarakis), Aristotle University of Thessaloniki, Thessaloniki, Greece; Division of Cardiac Surgery (Teoh), Southlake Regional Health Centre, Newmarket, Ont.; Population Health Research Institute (Vincent, Whitlock), Hamilton, Ont.; Department of Cardiothoracic Anesthesiology (Yared), Cleveland Clinic, Cleveland, Ohio; Division of Cardiology (Yusuf), Department of Medicine, McMaster University, Hamilton, Ont.

View Article

Download full-text PDF

Source
http://www.cmaj.ca/lookup/doi/10.1503/cmaj.181644
Publisher Site
http://dx.doi.org/10.1503/cmaj.181644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400656PMC
March 2019

Glucose lowering and the kidney: are all drug classes equal?

Lancet Diabetes Endocrinol 2018 11 3;6(11):835-837. Epub 2018 Oct 3.

The George Institute for Global Health, UNSW Sydney, Sydney, NSW 2042, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(18)30291-2DOI Listing
November 2018

ACCORDION: Ensuring That We Hear the Music Clearly.

Clin J Am Soc Nephrol 2018 11 25;13(11):1621-1623. Epub 2018 Oct 25.

Division of Renal and Metabolic, The George Institute for Global Health, University of New South Wales, Sydney, Australia;

View Article

Download full-text PDF

Source
http://cjasn.asnjournals.org/lookup/doi/10.2215/CJN.11370918
Publisher Site
http://dx.doi.org/10.2215/CJN.11370918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237047PMC
November 2018

Reducing cardiovascular risk in people with diabetes and kidney disease.

Med J Aust 2018 11;209(10):438-439

The George Institute for Global Health, Sydney, NSW.

View Article

Download full-text PDF

Source
November 2018

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.

Diabetes Obes Metab 2018 10;20 Suppl 3:14-18

George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13417
Publisher Site
http://dx.doi.org/10.1111/dom.13417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220936PMC
October 2018

Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.

Lancet Diabetes Endocrinol 2018 09 21;6(9):691-704. Epub 2018 Jun 21.

The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(18)30141-4DOI Listing
September 2018

Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Cochrane Database Syst Rev 2018 Sep 24;9:CD011798. Epub 2018 Sep 24.

Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/14651858.CD011798.pub2
Publisher Site
http://dx.doi.org/10.1002/14651858.CD011798.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513625PMC
September 2018

Baseline characteristics and enrichment results from the SONAR trial.

Diabetes Obes Metab 2018 08 1;20(8):1829-1835. Epub 2018 May 1.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13315
Publisher Site
http://dx.doi.org/10.1111/dom.13315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055730PMC
August 2018

Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist".

Circulation 2018 08;138(6):660-661

Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, CA (K.W.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035717DOI Listing
August 2018

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review.

Diabetes Res Clin Pract 2018 Jun 28;140:118-128. Epub 2018 Mar 28.

The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Australia; The Charles Perkins Centre, University of Sydney, Australia; Division of Epidemiology and Biostatistics, Imperial College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2018.03.027DOI Listing
June 2018

Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease: Moving from Single Trials to an Ongoing Platform.

Clin J Am Soc Nephrol 2018 06 26;13(6):946-948. Epub 2018 Apr 26.

George Institute for Global Health, University of New South Wales Sydney, Newtown Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.01290118DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989668PMC
June 2018

Renal trials in diabetes need a platform: time for a global approach?

Lancet Diabetes Endocrinol 2018 05 7;6(5):356-358. Epub 2017 Aug 7.

George Institute, University of New South Wales, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30263-2DOI Listing
May 2018

Are SGLT2 Inhibitors Ready for Prime Time for CKD?

Clin J Am Soc Nephrol 2018 02 11;13(2):318-320. Epub 2017 Sep 11.

George Institute for Global Health, Newtown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.07680717DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967433PMC
February 2018

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

N Engl J Med 2017 11;377(21):2099

University of Oxford, Oxford, United Kingdom

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1712572DOI Listing
November 2017

Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.

PLoS One 2017 12;12(9):e0184398. Epub 2017 Sep 12.

Renal Division and Institute of Nephrology, Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184398PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595305PMC
October 2017

Action plan for optimizing the design of clinical trials in chronic kidney disease.

Kidney Int Suppl (2011) 2017 Oct 20;7(2):138-144. Epub 2017 Sep 20.

Department of Medicine, Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kisu.2017.07.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341012PMC
October 2017

Effects of the Mediterranean Diet on Cardiovascular Outcomes-A Systematic Review and Meta-Analysis.

PLoS One 2016 10;11(8):e0159252. Epub 2016 Aug 10.

The George Institute for Global Health, Sydney Medical School, University of Sydney, PO Box M201, Missenden Road, Sydney, NSW, 2050, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159252PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980102PMC
August 2017

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

N Engl J Med 2017 08 12;377(7):644-657. Epub 2017 Jun 12.

From the George Institute for Global Health, Faculty of Medicine, UNSW Sydney (B.N., V.P.), the Charles Perkins Centre (B.N.), and the Royal North Shore Hospital (V.P., G.F.), University of Sydney, and the Faculty of Medicine, University of New South Wales (B.N.) - all in Sydney; Imperial College London, London (B.N.), and the Oxford Centre for Diabetes, Endocrinology, and Metabolism and Harris Manchester College, University of Oxford, Oxford (D.R.M.) - both in the United Kingdom; the Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA (K.W.M.); the University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (D.Z.); and Janssen Research and Development, Raritan, NJ (N.E., W.S., G.L., M.D.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1611925
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1611925DOI Listing
August 2017

Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis.

JAMA 2017 Jul;318(2):156-166

The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Sydney, New South Wales, Australia7The Charles Perkins Centre, University of Sydney, Sydney, New South Wales, Australia8Division of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2017.7967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541330PMC
July 2017

Reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST).

N Engl J Med 2017 07;377(3):298-300

George Institute for Global Health, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1703337DOI Listing
July 2017

Chronic kidney disease and the global NCDs agenda.

BMJ Glob Health 2017 6;2(2):e000380. Epub 2017 Jul 6.

Renal and Metabolic Division, George Institute for Global Health, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjgh-2017-000380DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717948PMC
July 2017

Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.

Am J Kidney Dis 2017 Jun 18;69(6):734-743. Epub 2016 Dec 18.

Cumming School of Medicine, Division of Nephrology, University of Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2016.10.018DOI Listing
June 2017

Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials.

J Hypertens 2017 06;35(6):1318-1325

aThe George Institute for Global Health bSydney Medical School, University of Sydney, Sydney, Australia cThe George Institute for Global Health, University of Oxford, Oxford, UK dBaker IDI Heart and Diabetes Institute, Melbourne, Australia eCentre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada fUniversity of Melbourne and Royal Melbourne Hospital, Melbourne, Australia gInstitute of Cardiovascular & Medical Sciences, BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK hChinese Hypertension League Institute, Beijing, China iUniversity of Milan-Bicocca and Istituto Auxologico Italiano, Milan, Italy jHôpital Bichat - Claude Bernard and Université Paris 7, Paris, France kInternational Centre for Circulatory Health, Imperial College lNational Institute for Health Research UCL Hospitals Biomedical Research Centre, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000001287DOI Listing
June 2017

The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.

Diabetes Obes Metab 2017 05 22;19(5):749-753. Epub 2017 Feb 22.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12864DOI Listing
May 2017

Comparison of exposure response relationship of atrasentan between North American and Asian populations.

Diabetes Obes Metab 2017 04 27;19(4):545-552. Epub 2017 Jan 27.

Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.12851DOI Listing
April 2017

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Cochrane Database Syst Rev 2017 02 27;2:CD009966. Epub 2017 Feb 27.

Diabetes and Vascular Research Program, Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD009966.pub2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464265PMC
February 2017

Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.

J Am Soc Nephrol 2017 Jan 18;28(1):368-375. Epub 2016 Aug 18.

The George Institute for Global Health, University of Sydney, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2016030278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198289PMC
January 2017

Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis.

Am J Kidney Dis 2017 Jan 1;69(1):69-77. Epub 2016 Oct 1.

Renal Division, Peking University First Hospital; Peking University Institute of Nephrology; Key Laboratory of Renal Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2016.07.033DOI Listing
January 2017

Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Kidney Int 2016 12;90(6):1175-1183

Diabetic Complications Division, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Folkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland; Diabetes and Obesity Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland; Abdominal Center Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2016.09.010DOI Listing
December 2016

Review: Revascularization and medical treatment may be similar in atherosclerotic renal artery stenosis.

Authors:
Vlado Perkovic

Ann Intern Med 2016 12;165(12):JC71

The George Institute for Global Health, University of SydneySydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/ACPJC-2016-165-12-071DOI Listing
December 2016

The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.

Am J Kidney Dis 2016 Oct 30;68(4):554-563. Epub 2016 Apr 30.

Australasian Kidney Trials Network, Brisbane, Australia; School of Medicine, The University of Queensland, Brisbane, Australia; Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2016.03.418DOI Listing
October 2016

The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysis.

Am J Kidney Dis 2016 Oct 3;68(4):591-598. Epub 2016 Jun 3.

Department of Clinical Epidemiology and Biostatistics, McMaster University, Ontario, Canada; Department of Medicine, McMaster University, Ontario, Canada; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2016.04.011DOI Listing
October 2016

Knowing what we do not know: statin therapy in advanced chronic kidney disease.

Lancet Diabetes Endocrinol 2016 10 29;4(10):801-3. Epub 2016 Jul 29.

The George Institute for Global Health, University of Sydney, Sydney, NSW 2000, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)30192-9DOI Listing
October 2016

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

J Am Coll Cardiol 2016 06;67(24):2888-99

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2016.02.082DOI Listing
June 2016

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.

Lancet Diabetes Endocrinol 2016 05 18;4(5):411-9. Epub 2016 Mar 18.

The George Institute for Global Health, University of Sydney, Camperdown, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia; Imperial College London, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(16)00052-8DOI Listing
May 2016

Interventions for lowering plasma homocysteine levels in dialysis patients.

Cochrane Database Syst Rev 2016 May 31(5):CD004683. Epub 2016 May 31.

Division of Nephrology, Massachusetts General Hospital, Scholars in Clinical Sciences Program, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD004683.pub4DOI Listing
May 2016

Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease.

Cochrane Database Syst Rev 2016 Apr 4;4:CD009631. Epub 2016 Apr 4.

Renal and Metabolic Division, The George Institute for Global Health, The University of Sydney, Level 10, King George V Building, 83-117 Missenden Rd, Camperdown, NSW, Australia, 2050.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/14651858.CD009631.pub2DOI Listing
April 2016